Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.

David M O'MalleyGiovanni Mendonca BarianiPhilippe Alexandre Cassier Aurélien Marabelle Aaron Richard HansenAna De Jesus AcostaWilson H MillerTamar Safra Antoine ItalianoLinda MileshkinLei XuFan JinKevin NorwoodMichele Maio

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)

Pembrolizumab demonstrated robust and durable antitumor activity and encouraging survival outcomes with manageable toxicity in patients with previously treated, advanced MSI-H/dMMR endometrial cancer.

Keyphrases

endometrial cancer
advanced non small cell lung cancer
oxidative stress
clinical trial
randomized controlled trial
phase ii
newly diagnosed
open label